Prostate Cancer Trial Results
Dutasteride Decreases Prostate Cancer Risk
(Posted: 04/12/2010) - Results from a large randomized clinical trial indicate that men at an increased risk for prostate cancer reduced their risk with regular use of the drug dutasteride (Avodart).
Higher Radiation Dose Reduces "Biochemical Recurrence" of Prostate Cancer
(Posted: 10/03/2005, Updated: 03/15/2010) - Men with early-stage prostate cancer who received higher doses of radiation were less likely than men who received the conventional dose to have rising levels of prostate-specific antigen (PSA), a phenomenon referred to as “biochemical recurrence,” according to the March 1, 2010, issue of Journal of Clinical Oncology.
Several Drugs Appear Effective for Hot Flashes in Men with Prostate Cancer
(Posted: 02/25/2010) - Clinical trial results published online December 4, 2009, in The Lancet, show that an antidepressant and two different hormone therapies reduced the number and intensity of hot flashes in men receiving hormonal treatment for advanced prostate cancer.
Denosumab Keeps Bones Strong during Prostate Cancer Treatment
(Posted: 10/28/2009) - Treatment with the monoclonal antibody denosumab increased bone mineral density (BMD) and reduced the risk of fractures in men who received a common treatment for prostate cancer that had not spread to other parts of the body, according to the results of a large, placebo-controlled clinical trial published in the August 20, 2009, New England Journal of Medicine.
Gabapentin Helps Hot Flashes From Prostate Cancer Treatment
(Posted: 06/20/2007, Updated: 03/19/2009) - The drug gabapentin (Neurontin®) effectively reduced the intensity and duration of hot flashes in a clinical trial of more than 200 men receiving hormonal treatment for their prostate cancer, according to findings presented at the 2007 ASCO meeting in Chicago.
(Posted: 04/12/2010) - Results from a large randomized clinical trial indicate that men at an increased risk for prostate cancer reduced their risk with regular use of the drug dutasteride (Avodart).
Higher Radiation Dose Reduces "Biochemical Recurrence" of Prostate Cancer
(Posted: 10/03/2005, Updated: 03/15/2010) - Men with early-stage prostate cancer who received higher doses of radiation were less likely than men who received the conventional dose to have rising levels of prostate-specific antigen (PSA), a phenomenon referred to as “biochemical recurrence,” according to the March 1, 2010, issue of Journal of Clinical Oncology.
Several Drugs Appear Effective for Hot Flashes in Men with Prostate Cancer
(Posted: 02/25/2010) - Clinical trial results published online December 4, 2009, in The Lancet, show that an antidepressant and two different hormone therapies reduced the number and intensity of hot flashes in men receiving hormonal treatment for advanced prostate cancer.
Denosumab Keeps Bones Strong during Prostate Cancer Treatment
(Posted: 10/28/2009) - Treatment with the monoclonal antibody denosumab increased bone mineral density (BMD) and reduced the risk of fractures in men who received a common treatment for prostate cancer that had not spread to other parts of the body, according to the results of a large, placebo-controlled clinical trial published in the August 20, 2009, New England Journal of Medicine.
Gabapentin Helps Hot Flashes From Prostate Cancer Treatment
(Posted: 06/20/2007, Updated: 03/19/2009) - The drug gabapentin (Neurontin®) effectively reduced the intensity and duration of hot flashes in a clinical trial of more than 200 men receiving hormonal treatment for their prostate cancer, according to findings presented at the 2007 ASCO meeting in Chicago.
